Composition for treating or preventing inflammatory skin disease, comprising, as active ingredient, immature citrus fruit extract, or synephrine or salt thereof
A technology for skin diseases, active ingredients, applied in the field of compositions for treating or preventing inflammatory skin diseases containing citrus immature fruit extract or synephrine or its salt as active ingredients, able to solve the citrus price collapse, etc. question
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0063] Embodiment 1: the preparation of citrus immature fruit extract
[0064] Unripe citrus was washed and pulverized, and extracted by immersing in ethanol for 5 days. After filtering and concentrating, freeze-drying is carried out, thereby preparing the powder of the citrus immature fruit extract.
Embodiment 2
[0065] Example 2: Isolation and analysis of synephrine from immature citrus fruits
[0066] The powder of the immature citrus fruit extract obtained in the above-mentioned Example 1 was purified by BulkC18 chromatography, and was divided into 11 fractional extracts, which were then passed through a C18 column using pre-high performance liquid chromatography (Prep-HPLC). Chromatography is used to separate the novel active ingredient substance from a second of these fractions. For the structure of the active ingredient substance, instruments such as nuclear magnetic resonance (NMR), infrared radiation (IR), ultraviolet light (UV) are used to confirm that the active ingredient substance is (4-[1-hydroxyl-2-(formazan amino)ethyl]phenol (molecular weight: 167.21), and the general chemical name is synephrine.
Embodiment 3
[0067] Example 3: Determination of the endocrine effect of citrus immature fruit extract or synephrine isolated therefrom on inhibiting eotaxin-1
[0068] Using liposome (superfect) (superfect, Quigen company) to insert eotaxin-1 reporter gene into human normal fibroblasts (humannormalfibroblast, NIH / 3T3, Department of Dermatology, Asia University) and carry out After conversion, at a concentration of 5% CO 2 Cultivate at 37°C for 24 hours in an incubator. Then, the transformed fibroblasts were seeded in 24-well microplates filled with DMEM medium so that each well had about 2×10 5 cells, and treated with 1ppm, 10ppm and 100ppm of immature citrus extract or 10μM, 100μM and 200μM of synephrine, respectively, with 50ng / ml of eotaxin-1 known to induce eotaxin-1 Interleukin-4 (R&D, Minneapolis, MN, IL-4) was co-treated and cells were harvested after 24 hours of incubation. Then, the collected cells were disrupted, reacted with a luciferase substrate to measure luminescence, and...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com